Cosentyx vs Bimzelx
Secukinumab vs Bimekizumab · Comparison Guide
Quick Comparison
| Feature | Cosentyx | Bimzelx |
|---|---|---|
| Generic Name | Secukinumab | Bimekizumab |
| Manufacturer | Novartis | UCB |
| Drug Class | IL-17A Inhibitor | IL-17A/F Inhibitor |
| Shared Conditions | Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis | |
Key Differences: Cosentyx vs Bimzelx
Bimzelx uniquely blocks both IL-17A and IL-17F while Cosentyx blocks only IL-17A. Clinical trials have shown Bimzelx achieves higher PASI 90/100 rates for psoriasis than IL-17A-only inhibitors. Bimzelx has a higher rate of oral candidiasis due to dual IL-17 blockade. Both are approved for PsA and AS. Bimzelx is newer and may be preferred for patients seeking maximum skin clearance.
💊 Cosentyx (Secukinumab)
- Class: IL-17A Inhibitor
- Manufacturer: Novartis
- Full Cosentyx information →
💊 Bimzelx (Bimekizumab)
- Class: IL-17A/F Inhibitor
- Manufacturer: UCB
- Full Bimzelx information →
Bimzelx uniquely blocks both IL-17A and IL-17F while Cosentyx blocks only IL-17A. Clinical trials have shown Bimzelx achieves higher PASI 90/100 rates for psoriasis than IL-17A-only inhibitors. Bimzelx has a higher rate of oral candidiasis due to dual IL-17 blockade. Both are approved for PsA and AS. Bimzelx is newer and may be preferred for patients seeking maximum skin clearance.
Neither Cosentyx nor Bimzelx is universally better — the right choice depends on your specific condition, disease severity, insurance formulary, and health history. Your prescriber will determine which is most appropriate based on your clinical situation. BiologicHealthPlus carries both and can help you compare your coverage and costs for either medication.
Switching between biologics is common. Your prescriber will evaluate your current treatment response and determine if a switch is appropriate. BiologicHealthPlus can coordinate the transition including prior authorization for your new medication.
Both Cosentyx and Bimzelx are covered by most commercial insurance plans, Medicare Part D, and Medicaid with prior authorization. BiologicHealthPlus handles insurance verification and prior authorization for both medications at no charge. Most insured patients pay $0–$35/month through manufacturer copay programs.
Cosentyx and Bimzelx both have high cash list prices ($4,000–$9,000/month range) but most commercially insured patients pay $0–$35/month through manufacturer savings programs. BiologicHealthPlus automatically enrolls every patient in all available savings programs at no charge.
✅ BiologicHealthPlus Carries Both Cosentyx and Bimzelx
We handle insurance verification, prior authorization, copay enrollment, and free cold-chain delivery for both medications. Contact us and we'll help you understand your options and costs.
Medical Disclaimer: This comparison is for educational purposes only. The choice between Cosentyx and Bimzelx should be made by your healthcare provider based on your specific medical history, disease severity, and individual circumstances. Last updated: July 2026.